Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 7239123, 14 pages
https://doi.org/10.1155/2018/7239123
Research Article

Quercetin Prevents Diastolic Dysfunction Induced by a High-Cholesterol Diet: Role of Oxidative Stress and Bioenergetics in Hyperglycemic Rats

1Pathophysiology Program, ICBM, Faculty of Medicine, University of Chile, Av. Salvador 486, Providencia, 7500922 Santiago, Chile
2International Center for Andean Studies, Universidad de Chile, Putre, Chile
3Department of Nutrition, Faculty of Medicine, University of Chile, Santiago, Chile
4Universidad de Viña del Mar, Región de Valparaíso, Chile
5Centro de Simulación Clínica, Universidad Iberoamericana, Santiago, Chile
6Servicios Médicos Veterinarios de Especialidad-VETCO, Santiago, Chile
7Discovery Biology, Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD 4111, Australia

Correspondence should be addressed to Catalina Carrasco-Pozo; moc.liamg@opacatac

Received 6 August 2017; Accepted 23 October 2017; Published 11 January 2018

Academic Editor: Vladimir Jakovljevic

Copyright © 2018 Rodrigo L. Castillo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Cai, L. Yang, H. J. He et al., “Antioxidant capacity responsible for a hypocholesterolemia is independent of dietary cholesterol in adult rats fed rice protein,” Gene, vol. 533, no. 1, pp. 57–66, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Csonka, M. Sarkozy, M. Pipicz, L. Dux, and T. Csont, “Modulation of hypercholesterolemia-induced oxidative/nitrative stress in the heart,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 3863726, 23 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Chtourou, A. B. Slima, M. Makni, R. Gdoura, and H. Fetoui, “Naringenin protects cardiac hypercholesterolemia-induced oxidative stress and subsequent necroptosis in rats,” Pharmacological Reports, vol. 67, no. 6, pp. 1090–1097, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Kamesh and T. Sumathi, “Antihypercholesterolemic effect of Bacopa monniera linn. on high cholesterol diet induced hypercholesterolemia in rats,” Asian Pacific Journal of Tropical Medicine, vol. 5, no. 12, pp. 949–955, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Panth, K. R. Paudel, and K. Parajuli, “Reactive oxygen species: a key hallmark of cardiovascular disease,” Advances in Medicine, vol. 2016, Article ID 9152732, 12 pages, 2016. View at Publisher · View at Google Scholar
  6. E. Osto, C. M. Matter, A. Kouroedov et al., “c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress,” Circulation, vol. 118, no. 20, pp. 2073–2080, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. D. G. Harrison, “From ST segments to endothelial pathophysiology: hypercholesterolemia and endothelial superoxide production,” The Journal of Clinical Investigation, vol. 124, no. 2, pp. 473–475, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Olea, M. T. Agapito, T. Gallego-Martin et al., “Intermittent hypoxia and diet-induced obesity: effects on oxidative status, sympathetic tone, plasma glucose and insulin levels, and arterial pressure,” Journal of Applied Physiology, vol. 117, no. 7, pp. 706–719, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Goncalves, A. F. Silva, P. G. Rodrigues et al., “Early cardiac changes induced by a hypercaloric Western-type diet in “subclinical” obesity,” American Journal of Physiology Heart and Circulatory Physiology, vol. 310, no. 6, pp. H655–H666, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Halliwell, “Dietary polyphenols: good, bad, or indifferent for your health?” Cardiovascular Research, vol. 73, no. 2, pp. 341–347, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Giampieri, J. M. Alvarez-Suarez, L. Mazzoni et al., “Polyphenol-rich strawberry extract protects human dermal fibroblasts against hydrogen peroxide oxidative damage and improves mitochondrial functionality,” Molecules, vol. 19, no. 6, pp. 7798–7816, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Carrasco-Pozo, K. N. Tan, M. Reyes-Farias et al., “The deleterious effect of cholesterol and protection by quercetin on mitochondrial bioenergetics of pancreatic beta-cells, glycemic control and inflammation: in vitro and in vivo studies,” Redox Biology, vol. 9, pp. 229–243, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. G. D'Andrea, “Quercetin: a flavonol with multifaceted therapeutic applications?” Fitoterapia, vol. 106, pp. 256–271, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. L. A. Ahmed, H. A. Salem, A. S. Attia, and M. E. El-Sayed, “Enhancement of amlodipine cardioprotection by quercetin in ischaemia/reperfusion injury in rats,” The Journal of Pharmacy and Pharmacology, vol. 61, no. 9, pp. 1233–1241, 2009. View at Publisher · View at Google Scholar
  15. S. Arumugam, R. A. Thandavarayan, W. Arozal et al., “Quercetin offers cardioprotection against progression of experimental autoimmune myocarditis by suppression of oxidative and endoplasmic reticulum stress via endothelin-1/MAPK signalling,” Free Radical Research, vol. 46, no. 2, pp. 154–163, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Katsiki, E. Theocharidou, A. Karagiannis, V. G. Athyros, and D. P. Mikhailidis, “Ezetimibe therapy for dyslipidemia: an update,” Current Pharmaceutical Design, vol. 19, no. 17, pp. 3107–3114, 2013. View at Publisher · View at Google Scholar
  17. Y. S. Yoon, S. Uchida, O. Masuo et al., “Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor,” Circulation, vol. 111, no. 16, pp. 2073–2085, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Gao, D. Ho, D. E. Vatner, and S. F. Vatner, “Echocardiography in mice,” Current Protocols in Mouse Biology, vol. 1, pp. 71–83, 2011. View at Publisher · View at Google Scholar
  19. P. J. Hissin and R. Hilf, “A fluorometric method for determination of oxidized and reduced glutathione in tissues,” Analytical Biochemistry, vol. 74, no. 1, pp. 214–226, 1976. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Nebot, M. Moutet, P. Huet, J. Z. Xu, J. C. Yadan, and J. Chaudiere, “Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol,” Analytical Biochemistry, vol. 214, no. 2, pp. 442–451, 1993. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Aebi, “Catalase A2 - Bergmeyer,” in Methods of Enzymatic Analysis, H. Ulrich, Ed., pp. 673–684, Academic Press, 2nd edition, 1974. View at Google Scholar
  23. L. Flohe and W. A. Gunzler, “Assays of glutathione peroxidase,” Methods in Enzymology, vol. 105, pp. 114–121, 1984. View at Publisher · View at Google Scholar
  24. C. Carrasco-Pozo, R. L. Castillo, C. Beltrán, A. Miranda, J. Fuentes, and M. Gotteland, “Molecular mechanisms of gastrointestinal protection by quercetin against indomethacin-induced damage: role of NF-κB and Nrf2,” The Journal of Nutritional Biochemistry, vol. 27, pp. 289–298, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. M. G. Hadera, O. B. Smeland, T. S. McDonald, K. N. Tan, U. Sonnewald, and K. Borges, “Triheptanoin partially restores levels of tricarboxylic acid cycle intermediates in the mouse pilocarpine model of epilepsy,” Journal of Neurochemistry, vol. 129, no. 1, pp. 107–119, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Bugger and C. Bode, “The vulnerable myocardium. Diabetic cardiomyopathy,” Hämostaseologie, vol. 35, no. 1, pp. 17–24, 2015. View at Publisher · View at Google Scholar
  27. E. Ulasova, J. Perez, B. G. Hill et al., “Quercetin prevents left ventricular hypertrophy in the Apo E knockout mouse,” Redox Biology, vol. 1, no. 1, pp. 381–386, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Shen, N. C. Ward, J. M. Hodgson et al., “Dietary quercetin attenuates oxidant-induced endothelial dysfunction and atherosclerosis in apolipoprotein E knockout mice fed a high-fat diet: a critical role for heme oxygenase-1,” Free Radical Biology and Medicine, vol. 65, pp. 908–915, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. W. M. Loke, J. M. Proudfoot, J. M. Hodgson et al., “Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 4, pp. 749–757, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. R. W. Hubbard, Y. Ono, and A. Sanchez, “Atherogenic effect of oxidized products of cholesterol,” Progress in Food & Nutrition Science, vol. 13, no. 1, pp. 17–44, 1989. View at Google Scholar
  31. T. Celik, U. C. Yuksel, F. Fici et al., “Vascular inflammation and aortic stiffness relate to early left ventricular diastolic dysfunction in prehypertension,” Blood Pressure, vol. 22, no. 2, pp. 94–100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Merlet, D. Busseuil, T. Mihalache-Avram et al., “HDL mimetic peptide CER-522 treatment regresses left ventricular diastolic dysfunction in cholesterol-fed rabbits,” International Journal of Cardiology, vol. 215, pp. 364–371, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Frustaci, J. Kajstura, C. Chimenti et al., “Myocardial cell death in human diabetes,” Circulation Research, vol. 87, no. 12, pp. 1123–1132, 2000. View at Publisher · View at Google Scholar
  34. C. Carrasco-Pozo, M. Gotteland, R. L. Castillo, and C. Chen, “3,4-Dihydroxyphenylacetic acid, a microbiota-derived metabolite of quercetin, protects against pancreatic β-cells dysfunction induced by high cholesterol,” Experimental Cell Research, vol. 334, no. 2, pp. 270–282, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Boudina and E. D. Abel, “Diabetic cardiomyopathy revisited,” Circulation, vol. 115, no. 25, pp. 3213–3223, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Munzel, T. Gori, J. F. Keaney Jr., C. Maack, and A. Daiber, “Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications,” European Heart Journal, vol. 36, no. 38, pp. 2555–2564, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. A. C. Kohler, C. M. Sag, and L. S. Maier, “Reactive oxygen species and excitation-contraction coupling in the context of cardiac pathology,” Journal of Molecular and Cellular Cardiology, vol. 73, pp. 92–102, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Kaludercic, E. Takimoto, T. Nagayama et al., “Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload,” Circulation Research, vol. 106, no. 1, pp. 193–202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Koncsos, Z. V. Varga, T. Baranyai et al., “Diastolic dysfunction in prediabetic male rats: role of mitochondrial oxidative stress,” American Journal of Physiology. Heart and Circulatory Physiology, vol. 311, no. 4, pp. H927–H943, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Chung, E. M. Jeong, Y. Go et al., “Mitochondria-targeted antioxidant ameliorates diet-induced diabetes and diastolic dysfunction,” Journal of the American College of Cardiology, vol. 61, no. 10, p. E597, 2013. View at Publisher · View at Google Scholar
  41. M. Luo, X. Guan, E. D. Luczak et al., “Diabetes increases mortality after myocardial infarction by oxidizing CaMKII,” The Journal of Clinical Investigation, vol. 123, no. 3, pp. 1262–1274, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Fiorani, A. Guidarelli, M. Blasa et al., “Mitochondria accumulate large amounts of quercetin: prevention of mitochondrial damage and release upon oxidation of the extramitochondrial fraction of the flavonoid,” The Journal of Nutritional Biochemistry, vol. 21, no. 5, pp. 397–404, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Carrasco-Pozo, E. Pastene, C. Vergara, M. Zapata, C. Sandoval, and M. Gotteland, “Stimulation of cytosolic and mitochondrial calcium mobilization by indomethacin in Caco-2 cells: modulation by the polyphenols quercetin, resveratrol and rutin,” Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 12, no. 61, p. 26, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Li, T. Ichikawa, J. S. Janicki, and T. Cui, “Targeting the Nrf2 pathway against cardiovascular disease,” Expert Opinion on Therapeutic Targets, vol. 13, no. 7, pp. 785–794, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Loboda, M. Damulewicz, E. Pyza, A. Jozkowicz, and J. Dulak, “Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism,” Cellular and Molecular Life Sciences, vol. 73, no. 17, pp. 3221–3247, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. L. E. Otterbein, R. Foresti, and R. Motterlini, “Heme oxygenase-1 and carbon monoxide in the heart: the balancing act between danger signaling and pro-survival,” Circulation Research, vol. 118, no. 12, pp. 1940–1959, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Li, W.-J. Zhang, and B. Frei, “Quercetin inhibits LPS-induced adhesion molecule expression and oxidant production in human aortic endothelial cells by p38-mediated Nrf2 activation and antioxidant enzyme induction,” Redox Biology, vol. 9, pp. 104–113, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. S. K. Panchal, H. Poudyal, and L. Brown, “Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats,” The Journal of Nutrition, vol. 142, no. 6, pp. 1026–1032, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Kumar, E. R. Kasala, L. N. Bodduluru, V. Kumar, and M. Lahkar, “Molecular and biochemical evidence on the protective effects of quercetin in isoproterenol-induced acute myocardial injury in rats,” Journal of Biochemical and Molecular Toxicology, vol. 31, no. 1, pp. 1–8, 2017. View at Publisher · View at Google Scholar · View at Scopus
  50. N. Ozbek, E. B. Bali, and C. Karasu, “Quercetin and hydroxytyrosol attenuates xanthine/xanthine oxidase-induced toxicity in H9c2 cardiomyocytes by regulation of oxidative stress and stress-sensitive signaling pathways,” General Physiology and Biophysics, vol. 34, no. 4, pp. 407–414, 2015. View at Publisher · View at Google Scholar
  51. X. Li, H. Wang, Y. Gao et al., “Protective effects of quercetin on mitochondrial biogenesis in experimental traumatic brain injury via the Nrf2 signaling pathway,” PLoS One, vol. 11, no. 10, 2016. View at Publisher · View at Google Scholar · View at Scopus
  52. P. S. Brookes, S. B. Digerness, D. A. Parks, and V. Darley-Usmar, “Mitochondrial function in response to cardiac ischemia-reperfusion after oral treatment with quercetin,” Free Radical Biology & Medicine, vol. 32, no. 11, pp. 1220–1228, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. D. M. Krzywanski, D. R. Moellering, J. L. Fetterman, K. J. Dunham-Snary, M. J. Sammy, and S. W. Ballinger, “The mitochondrial paradigm for cardiovascular disease susceptibility and cellular function: a complementary concept to Mendelian genetics,” Laboratory Investigation, vol. 91, no. 8, pp. 1122–1135, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Ramachandran, A. L. Levonen, P. S. Brookes et al., “Mitochondria, nitric oxide, and cardiovascular dysfunction,” Free Radical Biology & Medicine, vol. 33, no. 11, pp. 1465–1474, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. G. C. Rowe, A. Jiang, and Z. Arany, “PGC-1 coactivators in cardiac development and disease,” Circulation Research, vol. 107, no. 7, pp. 825–838, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. H. Bugger and E. D. Abel, “Mitochondria in the diabetic heart,” Cardiovascular Research, vol. 88, no. 2, pp. 229–240, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. M. G. Rosca and C. L. Hoppel, “Mitochondrial dysfunction in heart failure,” Heart Failure Reviews, vol. 18, no. 5, pp. 607–622, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. R. Ventura-Clapier, A. Garnier, and V. Veksler, “Transcriptional control of mitochondrial biogenesis: the central role of PGC-1α,” Cardiovascular Research, vol. 79, no. 2, pp. 208–217, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. J. G. Duncan, “Peroxisome proliferator activated receptor-alpha (PPARα) and PPAR gamma coactivator-1alpha (PGC-1α) regulation of cardiac metabolism in diabetes,” Pediatric Cardiology, vol. 32, no. 3, pp. 323–328, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. M. J. Roshon, J. A. Kline, L. R. Thornton, and J. A. Watts, “Cardiac UCP2 expression and myocardial oxidative metabolism during acute septic shock in the rat,” Shock, vol. 19, no. 6, pp. 570–6, 2003. View at Publisher · View at Google Scholar
  61. X. Wang, D. Liu, W. Chai, Y. Long, L. Su, and R. Yang, “The role of uncoupling protein 2 during myocardial dysfunction in a canine model of endotoxin shock,” Shock, vol. 43, no. 3, pp. 292–297, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. E. A. Boehm, B. E. Jones, G. K. Radda, R. L. Veech, and K. Clarke, “Increased uncoupling proteins and decreased efficiency in palmitate-perfused hyperthyroid rat heart,” American Journal of Physiology. Heart and Circulatory Physiology, vol. 280, no. 3, pp. H977–H983, 2001. View at Google Scholar
  63. S. Boudina, S. Sena, H. Theobald et al., “Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins,” Diabetes, vol. 56, no. 10, pp. 2457–2466, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Z. Duan, C. Y. Ivashchenko, M. W. Russell, D. S. Milstone, and R. M. Mortensen, “Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-γ both induce cardiac hypertrophy in mice,” Circulation Research, vol. 97, no. 4, pp. 372–379, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. N. H. Son, T. S. Park, H. Yamashita et al., “Cardiomyocyte expression of PPARγ leads to cardiac dysfunction in mice,” The Journal of Clinical Investigation, vol. 117, no. 10, pp. 2791–2801, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. C. J. Pol, M. Lieu, and K. Drosatos, “PPARs: protectors or opponents of myocardial function?” PPAR Research, vol. 2015, Article ID 835985, 19 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Kobori, S. Masumoto, Y. Akimoto, and H. Oike, “Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice,” Molecular Nutrition & Food Research, vol. 55, no. 4, pp. 530–540, 2011. View at Publisher · View at Google Scholar · View at Scopus